Blackrock Health Sciences Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.13
資產淨值: 41.03
成立日期: 28/03/2005
 
分析
市值分佈:
89.04%
大市值
1.01%
中市值
0.64%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:03) 總持有投資項目: 106  
0%
 
100%
     10大 (47.09%)
代號 名稱 佔比% 持有日期
NVCRNovoCure Limited0.1131/12/2025
IRONDisc Medicine0.1131/12/2025
EWTXEdgewise Therapeutics0.1031/12/2025
PTCTPTC Therapeutics0.1031/12/2025
MTDMettler-Toledo International0.1031/12/2025
ZLDPFZealand Pharma A/S0.0931/12/2025
WVEWave Life Sciences Ltd0.0931/12/2025
DNLIDenali Therapeutics0.0831/12/2025
DYNDyne Therapeutics0.0831/12/2025
ALCAlcon0.0831/12/2025
BEAMBeam Therapeutics0.0731/12/2025
KYMRKymera Therapeutics0.0631/12/2025
BNTXBioNTech SE American Depositary Share0.0631/12/2025
PCVXVaxcyte0.0631/12/2025
BHVNBiohaven Ltd0.0631/12/2025
RGNXREGENXBIO0.0531/12/2025
CGONCG Oncology0.0431/12/2025
ALLOAllogene Therapeutics0.0331/12/2025
NYXHNyxoah SA0.0231/12/2025
AUTLAutolus Therapeutics plc0.0231/12/2025
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.